ATE218369T1 - Verfahren zur herstellung von immunoaktiven mittel und impfstoffe - Google Patents

Verfahren zur herstellung von immunoaktiven mittel und impfstoffe

Info

Publication number
ATE218369T1
ATE218369T1 AT97908244T AT97908244T ATE218369T1 AT E218369 T1 ATE218369 T1 AT E218369T1 AT 97908244 T AT97908244 T AT 97908244T AT 97908244 T AT97908244 T AT 97908244T AT E218369 T1 ATE218369 T1 AT E218369T1
Authority
AT
Austria
Prior art keywords
pct
producing
immunogenic product
sec
vaccines
Prior art date
Application number
AT97908244T
Other languages
English (en)
Inventor
Ab Eurocine
Original Assignee
Ab Eurocine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Eurocine filed Critical Ab Eurocine
Application granted granted Critical
Publication of ATE218369T1 publication Critical patent/ATE218369T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97908244T 1996-03-26 1997-03-17 Verfahren zur herstellung von immunoaktiven mittel und impfstoffe ATE218369T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9601158A SE9601158D0 (sv) 1996-03-26 1996-03-26 Method of producing immunogenic products and vaccines
PCT/EP1997/001321 WO1997035613A1 (en) 1996-03-26 1997-03-17 Method of producing immunogenic products and vaccines

Publications (1)

Publication Number Publication Date
ATE218369T1 true ATE218369T1 (de) 2002-06-15

Family

ID=20401951

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97908244T ATE218369T1 (de) 1996-03-26 1997-03-17 Verfahren zur herstellung von immunoaktiven mittel und impfstoffe

Country Status (8)

Country Link
US (1) US6165468A (de)
EP (1) EP0894008B1 (de)
JP (1) JP2000507252A (de)
AT (1) ATE218369T1 (de)
AU (1) AU2027797A (de)
DE (1) DE69713089T2 (de)
SE (1) SE9601158D0 (de)
WO (1) WO1997035613A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797275B1 (en) * 1998-12-04 2004-09-28 The United States Of America As Represented By The Department Of Health And Human Services Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
SE9900496D0 (sv) * 1999-02-12 1999-02-12 Pharmatrix Ab Vaccine formulation
AU3158900A (en) * 1999-02-25 2000-09-14 Smithkline Beecham Biologicals (Sa) Immunogens comprising a peptide and a carrier derived from h.influenzae protein
KR100642044B1 (ko) 1999-03-19 2006-11-10 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB9909077D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
US9486515B2 (en) 2005-06-27 2016-11-08 Glaxosmithkline Biologicals S.A. Immunogenic composition
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720883B2 (ja) * 1985-03-04 1995-03-08 ダナ−フア−バ− キヤンサ− インステイテユ−ト，インコ−ポレイテツド 免疫毒素及びその製造方法
NZ223009A (en) * 1986-12-31 1990-06-26 Nl Rivm Of Thoven Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
IE62463B1 (en) * 1988-07-07 1995-02-08 Res Dev Foundation Immunoconjugates for cancer diagnosis and therapy
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5370872A (en) * 1991-08-12 1994-12-06 Swiss Serum And Vaccine Institute Berne Escherichia coliO-polysaccharide-protein conjugate vaccine
US5622929A (en) * 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US5445817A (en) * 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines

Also Published As

Publication number Publication date
AU2027797A (en) 1997-10-17
DE69713089D1 (de) 2002-07-11
DE69713089T2 (de) 2003-01-02
EP0894008A1 (de) 1999-02-03
WO1997035613A1 (en) 1997-10-02
EP0894008B1 (de) 2002-06-05
JP2000507252A (ja) 2000-06-13
SE9601158D0 (sv) 1996-03-26
US6165468A (en) 2000-12-26

Similar Documents

Publication Publication Date Title
TR199900848T2 (xx) Oksadiazoller, elde edilmeleri ve ila� olarak kullan�mlar�.
DE69317433D1 (de) Ungesättigte aliphatische dicarbonsäuren
DE69529748D1 (de) Polynukleotide vakzine gegen den papilloma virus
ES2001152B3 (es) Preparados cosmeticos a base de n anas, nuevas n imiento para su obtencion.
NO963508L (no) Urease-basert vaksine og behandling av Helicobacter-infeksjon
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
ATE218369T1 (de) Verfahren zur herstellung von immunoaktiven mittel und impfstoffe
ATE188960T1 (de) Alk(en)yldicarbonsäurebisester, deren verwendung sowie verfahren zu deren herstellung
YU89691A (sh) Postupak za dobijanje stereoselektivnih derivata fenilizoserina
ATE112239T1 (de) Vaterit und verfahren zu dessen herstellung.
ATE211927T1 (de) Verfahren zur virusinaktivierung in gegenwart eines polyethers und eines agens
ATE169641T1 (de) Verfahren zur herstellung von stärkeabbauprodukten
SE9900496D0 (sv) Vaccine formulation
TW367326B (en) Pyrimidine derivative, process for the preparation thereof and a pharmaceutical composition containing same
DE59505719D1 (de) Verfahren zur herstellung von polyasparaginsäure
ATE246515T1 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
NO951750D0 (no) Renset "nontypable" Haemophilus influenzae P5 protein som en vaksine for "nontypable" Haemophilus influenzae stamme
DE69521200D1 (de) Formulierung von energie
ATE206456T1 (de) Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen
ATE348916T1 (de) Zusammensetzung zur behandlung eines hydrophilen papierproduktes
AU3057100A (en) Compositions for oxidation dyeing keratin fibres comprising a cationic coupler, novel cationic couplers, their use for oxidation dyeing and dyeing methods
DE69413952D1 (de) Extraktion von zellgebundenem protein von bordetella
AU3473595A (en) Novel phosphane oxides, method of preparing them and drugs containing these compounds
DE69504188D1 (de) Verfahren zur herstellung von 5-amino-1,3-dioxanen
ATE221068T1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties